Who has invested in NMD Pharma?

Jeito Capital, INKEF Capital, Novo Holdings, Roche Venture Fund, Lundbeck Foundation, Capnova are named among the investors backing NMD Pharma.

NMD Pharma Funding: $79M Raised, Series B (2022)

NMD Pharma funding overview

NMD Pharma is based in Aarhus, Denmark. NMD Pharma has raised $79M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in February 2022. The round record for NMD Pharma runs through 2022; nothing later has been disclosed. Investors on record include Jeito Capital, INKEF Capital, Novo Holdings, Roche Venture Fund, Lundbeck Foundation, Capnova. 6 distinct backers are named across the disclosed rounds.

NMD Pharma at a glance

Total raised: $79M
Latest round: Series B
Latest round date: February 2022
Headquarters: Aarhus, Denmark
Notable investors: Jeito Capital, INKEF Capital, Novo Holdings, Roche Venture Fund, Lundbeck Foundation, Capnova

Frequently asked about NMD Pharma funding

How much has NMD Pharma raised?: NMD Pharma has raised $79M in total disclosed funding across the rounds on record.
Who has invested in NMD Pharma?: Jeito Capital, INKEF Capital, Novo Holdings, Roche Venture Fund, Lundbeck Foundation, Capnova are named among the investors backing NMD Pharma.
What was the latest NMD Pharma funding round?: The most recent disclosed round is a Series B, announced in February 2022.
Where is NMD Pharma based?: NMD Pharma is based in Aarhus, Denmark.
When did NMD Pharma last raise?: The last disclosed NMD Pharma round closed in February 2022 at Series B.

NMD Pharma totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Aarhus below to benchmark round size and investor mix.

NMD Pharma Funding: $79M Raised, Series B (2022)

NMD Pharma funding overview

NMD Pharma at a glance

Frequently asked about NMD Pharma funding

Companies related to NMD Pharma (18)

Browse related funding lists (6)